Report cover image

North America Animal Sedative Market Size, Share & Trends Analysis Report By Route of Administration, By Animal Type, By Drug Class, By End Use (Hospitals and Specialty Centers), By Application (Surgical, Diagnostic, and Others), By Country and Growth For

Publisher Knowledge Based Value (KBV) Research
Published Jul 19, 2024
Length 118 Pages
SKU # KBV19028646

Description

North America Animal Sedative Market Size, Share & Trends Analysis Report By Route of Administration, By Animal Type, By Drug Class, By End Use (Hospitals and Specialty Centers), By Application (Surgical, Diagnostic, and Others), By Country and Growth Forecast, 2024 - 2031


The North America Animal Sedative Market would witness market growth of 5.2% CAGR during the forecast period (2024-2031).

The US market dominated the North America Animal Sedative Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $130,740.2 Thousands by 2031. The Canada market is experiencing a CAGR of 7.2% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7.7% during (2024 - 2031).

Animal sedatives are pharmaceutical drugs used to induce sedation or calmness in animals for various medical procedures, handling, or behavioral management. These medications act on the central nervous system, producing effects such as relaxation, reduced anxiety, muscle relaxation, and, in some cases, sleepiness. Veterinarians commonly administer them to facilitate safe and stress-free handling of animals during examinations, surgeries, diagnostic procedures, and transportation.

In addition, animal sedatives are essential pharmaceuticals used across diverse sectors of veterinary care to manage animals' behavior and physical responses during medical procedures, examinations, and handling. Sedatives are commonly used in veterinary clinics and hospitals to calm pets during routine examinations, vaccinations, dental cleanings, and minor surgical procedures.

As the pet population in Canada grows, so does the need for veterinary care, including procedures that may require sedation. According to the Canadian Animal Health Institute, the number of dogs and cats in Canada increased between 2020 and 2022, rising from 8.1 million to 8.5 million for cats and from 7.7 million to 7.9 million for dogs. With more Canadians owning pets, there is a corresponding expansion in the number of veterinary clinics, hospitals, and practices across the country. This expansion increases the availability of veterinary services and drives the demand for pharmaceutical products, including sedatives, used in these facilities. Also, 3% rise from 58% in 2020 to 61% in 2022 in the number of cats reported to have visited a vet in the previous 12 months. Hence, increasing clinical visits and the rising population of pets in the region are driving the market's growth.

Based on Route of Administration, the market is segmented into Parenteral and Oral. Based on Animal Type, the market is segmented into Dogs, Cats, Horses, and Others. Based on Drug Class, the market is segmented into Alpha-2 Adrenergic Receptor Agonists, Phenothiazines, Benzodiazepines, Butyrophenones, and Others. Based on End Use, the market is segmented into Hospitals and Specialty Centers. Based on Application, the market is segmented into Surgical, Diagnostic, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • Zoetis, Inc.
  • Virbac
  • Dechra Pharmaceuticals PLC
  • Merck & Co., Inc.
  • Bimeda, Inc.
  • Ouro Fino Saude Animal Participacoes S.A.
  • vetcare. fi.
  • Chanelle Pharma (Exponent)
  • Randlab Australia Pty Ltd.
  • Troy Laboratories Pty Ltd.
North America Animal Sedative Market Report Segmentation

By Route of Administration
  • Parenteral
  • Oral
By Animal Type
  • Dogs
  • Cats
  • Horses
  • Others
By Drug Class
  • Alpha-2 Adrenergic Receptor Agonists
  • Phenothiazines
  • Benzodiazepines
  • Butyrophenones
  • Others
By End Use
  • Hospitals
  • Specialty Centers
By Application
  • Surgical
  • Diagnostic
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

118 Pages
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Animal Sedative Market, by Route of Administration
1.4.2 North America Animal Sedative Market, by Animal Type
1.4.3 North America Animal Sedative Market, by Drug Class
1.4.4 North America Animal Sedative Market, by End Use
1.4.5 North America Animal Sedative Market, by Application
1.4.6 North America Animal Sedative Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. North America Animal Sedative Market by Route of Administration
4.1 North America Parenteral Market by Region
4.2 North America Oral Market by Region
Chapter 5. North America Animal Sedative Market by Animal Type
5.1 North America Dogs Market by Country
5.2 North America Cats Market by Country
5.3 North America Horses Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Animal Sedative Market by Drug Class
6.1 North America Alpha-2 Adrenergic Receptor Agonists Market by Country
6.2 North America Phenothiazines Market by Country
6.3 North America Benzodiazepines Market by Country
6.4 North America Butyrophenones Market by Country
6.5 North America Others Market by Country
Chapter 7. North America Animal Sedative Market by End Use
7.1 North America Hospitals Market by Country
7.2 North America Specialty Centers Market by Country
Chapter 8. North America Animal Sedative Market by Application
8.1 North America Surgical Market by Country
8.2 North America Diagnostic Market by Country
8.3 North America Others Market by Country
Chapter 9. North America Animal Sedative Market by Country
9.1 US Animal Sedative Market
9.1.1 US Animal Sedative Market by Route of Administration
9.1.2 US Animal Sedative Market by Animal Type
9.1.3 US Animal Sedative Market by Drug Class
9.1.4 US Animal Sedative Market by End Use
9.1.5 US Animal Sedative Market by Application
9.2 Canada Animal Sedative Market
9.2.1 Canada Animal Sedative Market by Route of Administration
9.2.2 Canada Animal Sedative Market by Animal Type
9.2.3 Canada Animal Sedative Market by Drug Class
9.2.4 Canada Animal Sedative Market by End Use
9.2.5 Canada Animal Sedative Market by Application
9.3 Mexico Animal Sedative Market
9.3.1 Mexico Animal Sedative Market by Route of Administration
9.3.2 Mexico Animal Sedative Market by Animal Type
9.3.3 Mexico Animal Sedative Market by Drug Class
9.3.4 Mexico Animal Sedative Market by End Use
9.3.5 Mexico Animal Sedative Market by Application
9.4 Rest of North America Animal Sedative Market
9.4.1 Rest of North America Animal Sedative Market by Route of Administration
9.4.2 Rest of North America Animal Sedative Market by Animal Type
9.4.3 Rest of North America Animal Sedative Market by Drug Class
9.4.4 Rest of North America Animal Sedative Market by End Use
9.4.5 Rest of North America Animal Sedative Market by Application
Chapter 10. Company Profiles
10.1 Zoetis, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.6 SWOT Analysis
10.2 Virbac
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Recent strategies and developments:
10.2.4.1 Product Launches and Product Expansions:
10.2.5 SWOT Analysis
10.3 Dechra Pharmaceuticals PLC
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental & Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Merck & Co., Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 SWOT Analysis
10.5 Bimeda, Inc.
10.5.1 Company Overview
10.5.2 Recent strategies and developments:
10.5.2.1 Product Launches and Product Expansions:
10.5.3 SWOT Analysis
10.6 Ouro Fino Saude Animal Participacoes S.A.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expenses
10.7 vetcare. fi.
10.7.1 Company Overview
10.8 Chanelle Pharma (Exponent)
10.8.1 Company Overview
10.9 Randlab Australia Pty Ltd.
10.9.1 Company Overview
10.10. Troy Laboratories Pty Ltd.
10.10.1 Company Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us